Our TCGA data set indicated eIF6 overexpression reduced patients overall survival in HCC, which was in accord with existing results from NSCLC and OV [21, 23], highly suggesting that it was a predictor for overall survival in HCC. This evidence concerns the gene EIF6 and hepatocellular carcinoma.